findmyKOL
Clinical trialNCT03963752CompletedPhase 4Interventional

Clinical Trial of Rapid Progressive Central Precocious Puberty With Integrative Chinese and Western Medicine

SponsorChildren's Hospital of Fudan UniversityEnrollment126Idiopathic Precocious Puberty
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Our study used a randomized controlled trial to validate the clinical efficacy of a combination of traditional Chinese and Western medicine in the treatment of children with rapid progressive central precocious puberty.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Children'S Hospital of Fudan University

    Shanghai, Shanghai Municipality, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Leuprorelin Acetate 3.75mg InjectionMegestrol →Ziyinxiehuo Granules Herbs
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Aug 2019
Primary completion
15 Aug 2022
Completion
30 Sept 2022
Last update posted
7 Feb 2024
Registered enrollment
126
Registry id
NCT03963752

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.